Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 18 of 18 for “"Antidiabetic agents"”.
-
Design, synthesis and biological evaluation of antidiabetic agents
… Consequently, there exists a need for novel antidiabetic agents for the treatment of T2D. The retinol transporter, RBP4, is a possible target for the treatment of T2D as elevated levels of this protein are found in T2D sufferers. Compounds that reduce the levels of RBP4 in vivo have been …
-
Stereocontrolled Synthesis of Lactam-fused Tetrahydropyrans as Potential Antidiabetic Agents
… some drawbacks such as the need for expensive reagents and catalysts, substrate limitations, and environmentally unfriendly conditions. Seeking to develop a new strategy to produce lactam-fused tetrahydropyrans, we successfully designed a modular, cost-saving, transition metal-free, and …
-
The usage of antidiabetic drugs : a managed care approach
… this study was to review the usage and cost of antidiabetic drugs and to determine the influence of the pricing regulations on the cost of these drugs. This research can be classified as retrospective and quantitative. Data were obtained from a prescription claims database, and the study …
-
Identification of Putative Drug Candidates for Type 2 Diabetes Using the CANDO Platform
… signatures were generated to compare known antidiabetic agents with a large set of approved compounds. Benchmark analyzes, including IA, AIA, NIA, NAIA, NDCG, and nNDCG, were performed to evaluate prediction performance. Furthermore, target similarity analyses were performed using Jaccard …
-
Prescribing patterns of hypoglycaemic drugs in the treatment of Type 2 Diabetes Mellitus in public institutions in Lesotho
… in Maseru district of Lesotho. Data on costs of antidiabetic agents was collected from purchase invoices provided by the pharmacy department of Domiciliary Health Center. Results showed that the overall ratio of males to females was 1.3. There were no statistical difference in DM prevalence …
-
Pharmacological Studies of Antidiabetic Chinese Herbs
… have all been employed by the Chinese as oral antidiabetic agents and reported by Min (1928), Kin (1931), and Li et al. (1936) to possess hypoglycemic activity. This prompted the pharmacological studies of these herbs. Materials and methods. Their pharmacognosy was condensed from all available …
-
Mung Bean Proteins, Protein Hydrolysates, and Peptides: Role in Rice Starch Digestion and Glucose Absorption
In diabetes management, antidiabetic agents are often used, but they usually have side effects. Natural compounds, such as proteins, protein hydrolysates, and bioactive peptides from legumes have been reported for their antidiabetic activities. Mung bean is an excellent source of protein, but its …
-
Evaluation of patient demographics, clinical characteristics, and cardiovascular outcomes in patients with type 2 diabetes newly initiated on sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and other antidiabetic medications
… receptor agonists (GLP-1RAs), and other antidiabetic medications (oADMs). Methods: This retrospective new user cohort study used administrative claims and electronic health record data from an integrated delivery network in Texas. Patients ages ≥18 years with T2D and ≥1 prescription claim …
-
Initial Combination Therapy Versus Conventional Stepwise Approach for the Treatment of Newly Diagnosed Drug Naïve Type 2 Diabetes Patients
… followed by stepwise addition of other antidiabetic agents. However, clinical trials highlight the advantages of early intensive treatment, including better long-term management and reduced complications. This study aimed to: 1. describe real-world treatment patterns with respect to …
-
Η επίδραση του καπνίσματος στη λειτουργία του αυτόνομου νευρικού συστήματος της καρδιάς σε ασθενείς με σακχαρώδη διαβήτη τύπου 2
… in patients with Type 2 DM treated withoral antidiabetic agents. A total of 70 patients with Type 2 DM (35 chronicsmokers, 35 non-smokers) were included in the study. All patients underwentcontinuous ECG Holter monitoring for 24 hours and analysis of time- andfrequency-domain measures of …
-
Μελέτη της επίδρασης των αντιδιαβητικών παραγόντων στις συνάψεις των πυραμιδικών κυττάρων του ιππόκαμπου και του πιθανού τους ρόλου στην αντιμετώπιση της νόσου Alzheimer
… is an urgent need to develop new pharmaceutical agents for the treatment of the disease and in this direction a great research effort is being made worldwide. Recent work, both clinical and experimental, indicates that neurodegenerative disorders display a coexisting metabolic dysfunction which …
-
IDENTIFICATION OF A NOVEL SMALL-MOLECULE PPARGAMMA ACTIVATOR THAT INDUCES AUTOPHAGIC CELL DEATH IN CANCER CELLS
… ligand 15d-PGJ2 and synthetic antidiabetic agents known as the thiazolidinediones (TZDs). These conventional agonists, however, have been historically plagued with safety and potency issues. Moreover, studies using these agents to decipher exact mechanisms of PPARgamma-induced …
-
Functional Significance of Islet Amyloid Polypeptide Anti-fibrillation Compounds as a Novel Treatment for Type 2 Diabetes Management
… toxicity. In comparison to other more popular antidiabetic targets, however, IAPP fibrillation is largely understudied as a potential treatment of T2D. Furthermore, natural compounds such as polyphenols, peptides, and polysaccharides, are not commonly considered as antidiabetic agents. Thus, …
-
Effect of glycemic control on markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus: the role of diabetes duration and overt cardiovascular disease
… aimed to investigate the effect of intensive antidiabetic treatment on vascular indices in patients with DM2. The same markers of subclinical atherosclerosis were assessed before and after improvement of glycemic control. Patients who did not achieve an absolute HbA1c reduction of at least …
-
Contribution to Safety Assessment of New Antidiabetics during Pregnancy – A Placenta-based $\textit{Ex Vivo}$ and $\textit{In Vitro}$ Study
… gestational diabetes mellitus. Although various antidiabetic pharmaceuticals for T2DM are available, many cannot be used during pregnancy due to limited safety data, despite their efficacy in glycaemic control, weight reduction, and cardiovascular and renal protection. Sodium-glucose …
-
STUDY OF THE MOLECULAR MECHANISM UNDERLYING PPAR ACTIVATION BY LT175, A NOVEL DUAL PPARA/G LIGAND THAT AMELIORATES THE METABOLIC PROFILE AND INSULIN SENSITIVITY IN A MOUSE MODEL OF INSULIN RESISTANCE
… devoid of the side effects of the marketed antidiabetic agents thiazolidinediones and the dual PPAR α/γ agonists glitazars. To this purpose, it’s fundamental to understand the molecular mechanism underlying PPAR activation induced by different ligands. The aim of my project is to study the …